Latest News

Many people becoming reinfected as BA.5 dominates new COVID-19 cases


 

When the COVID-19 pandemic first began, the general thought was that once people were infected, they were then protected from the virus.

But a new analysis by ABC News shows that more and more Americans are getting the virus again.

It’s hard to say how many. The ABC News analysis found at least 1.6 million reinfections in 24 states, but the actual number is probably a lot higher.

“These are not the real numbers because many people are not reporting cases,” Ali Mokdad, MD, an epidemiologist with the University of Washington, Seattle, told ABC.

The latest variant, BA.5, has become the dominant strain in the United States, making up more than 65% of all COVID-19 cases as of July 13, according to data from the CDC.

Prior infections and vaccines aren’t providing as much protection against the newly dominant BA.5 strain as they did against earlier variants.

But evidence doesn’t show this subvariant of Omicron to be more harmful than earlier, less transmissible versions.

Several factors are contributing to rising reinfections, experts say. For example, fewer people are wearing masks than in the first year or so of the pandemic. Dr. Mokdad said just 18% of Americans reported always wearing a mask in public at the end of May, down from 44% the year before.

The emergence of the Omicron variant, of which BA.5 is a subvariant, is indicating that less protection is being offered by prior infections.

A version of this article first appeared on WebMD.com.

Recommended Reading

WHO tracking new Omicron subvariant in India
Journal of Clinical Outcomes Management
U.S. allows pharmacists to prescribe Paxlovid directly
Journal of Clinical Outcomes Management
‘Myriad’ dermatologic reactions after COVID-19 vaccination
Journal of Clinical Outcomes Management
Long COVID-19 in children and adolescents: What do we know?
Journal of Clinical Outcomes Management
Obesity links to faster fading of COVID vaccine protection
Journal of Clinical Outcomes Management
BA.4 and BA.5 subvariants are more evasive of antibodies, but not of cellular immunity
Journal of Clinical Outcomes Management
Children and COVID: Vaccination a harder sell in the summer
Journal of Clinical Outcomes Management
FDA grants emergency authorization for Novavax COVID vaccine
Journal of Clinical Outcomes Management
Some have heavier periods after COVID vaccine
Journal of Clinical Outcomes Management
Cancer drug significantly cuts risk for COVID-19 death
Journal of Clinical Outcomes Management